Bio-Rad Laboratories, Inc. (BIO) vs Oscar Health, Inc. (OSCR)

BIO leads on 7 of 13 compared metrics.

A side-by-side comparison of Bio-Rad Laboratories, Inc. and Oscar Health, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of June 21, 2026. The ● marks the stronger figure on each row (cheaper multiple, higher margin/return).

Compare

Total return — BIO vs OSCR

growth of $100 · last 5y
BIO -52.2%OSCR -18.4%OSCR compounded faster
050100Start $10020222023202420252026$48$82
BIO OSCR

BIO vs OSCR: by the numbers

  • BIO is the larger company ($7.64B vs $7.36B market cap).
  • BIO is profitable (6.52% net margin) while OSCR runs a net loss (-0.30%).
  • OSCR grew revenue faster over the past five years (73.14% vs -0.84% CAGR).

Which is better, BIO or OSCR?

Metric tally: BIO 7 · OSCR 6

It depends on what you're optimizing for:

GrowthOSCR(faster 5Y revenue CAGR)
QualityBIO(higher ROIC)

Metrics side by side

Valuation

MetricBIOOSCR
P/E ratio46.53
Forward P/E28.3421.28
P/S ratio2.940.70
P/B ratio1.115.63
EV / EBITDA18.06259.51
FCF yield4.69%29.85%

Profitability

MetricBIOOSCR
Gross margin51.87%17.39%
Operating margin9.25%0.08%
Net margin6.52%-0.30%
ROE2.46%-2.37%
ROIC2.04%-27.10%

Growth (annualized)

MetricBIOOSCR
Revenue CAGR (5Y)-0.84%73.14%
EPS CAGR (5Y)-26.27%
FCF CAGR (5Y)-7.57%46.32%
Total return CAGR (5Y)-14.63%3.55%

Frequently asked

Which is better, BIO or OSCR?
It depends on your goal. growth: OSCR (faster 5Y revenue CAGR); quality: BIO (higher ROIC). Across all compared metrics, BIO leads 7 to 6.
Which has grown faster, BIO or OSCR?
Over the past five years, OSCR grew revenue faster — BIO at a -0.84% CAGR versus OSCR at 73.14%.
Is BIO or OSCR more profitable?
BIO runs the higher net margin — BIO at 6.52% versus OSCR at -0.30%.
Which has been the better investment, BIO or OSCR?
Over the past 5-year, BIO delivered the higher annualized total return — BIO at 7.20% versus OSCR at 3.55%. Past performance doesn't predict future results.

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified June 21, 2026.